1. Market Research
  2. > Healthcare Market Trends
  3. > Healthcare Analysis & Statistics 2022 - Europe (p4)

Healthcare Analysis & Statistics 2022 - Europe (p4)

91-120 of about 200 reports

IMGN632 - Emerging Insight and Market Forecast - 2030

  • $ 3250
  • February 2021
  • 30 pages

“IMGN632 - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for Blastic Plasmacytoid Dendritic Cell Neoplasm in 7 Major Markets. ...

  • Europe
  • Japan
  • Cell Therapy
  • Research And Development
  • Industry analysis
  • Health Expenditure

DEXMECAMYLAMINE- Emerging Insight and Market Forecast – 2030

  • $ 3250
  • February 2021
  • 30 pages

“DEXMECAMYLAMINE- Emerging Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product for Palmar hyperhidrosis in 7 Major Markets. A detailed ...

  • Europe
  • Japan
  • Dermatological Condition
  • Research And Development
  • Industry analysis
  • Health Expenditure

ELAFIBRANOR - Emerging Insight and Market Forecast - 2030

  • $ 3250
  • February 2021
  • 30 pages

“ELAFIBRANOR - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for Primary Biliary Cirrhosis in 7 Major Markets. A detailed ...

  • Europe
  • Japan
  • Autoimmune Disease
  • Research And Development
  • Industry analysis
  • Health Expenditure

SELADELPAR - Emerging Insight and Market Forecast - 2030

  • $ 3250
  • February 2021
  • 30 pages

“SELADELPAR - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for Primary Biliary Cirrhosis in 7 Major Markets. A detailed picture ...

  • Europe
  • Japan
  • Autoimmune Disease
  • Research And Development
  • Industry analysis
  • Health Expenditure

Enhertu - Drug Insight and Market Forecast - 2030

  • $ 2750
  • February 2021
  • 30 pages

Overview “Enhertu - Drug Insight and Market Forecast - 2030” report outlays comprehensive insights of the product indicated for the treatment of its approved condition. A detailed picture of the Enhertu ...

  • Europe
  • Japan
  • Clinical Trial
  • Breast Cancer
  • Industry analysis
  • Health Expenditure

Kadcyla - Drug Insight and Market Forecast - 2030

  • $ 2750
  • February 2021
  • 30 pages

Overview “Kadcyla - Drug Insight and Market Forecast - 2030” report outlays comprehensive insights of the product indicated for the treatment of its approved condition. A detailed picture of the Kadcyla ...

  • Europe
  • Japan
  • Clinical Trial
  • Breast Cancer
  • Industry analysis
  • Health Expenditure
  • Drug Approval

Nerlynx - Drug Insight and Market Forecast - 2030

  • $ 2750
  • February 2021
  • 30 pages

Overview “Nerlynx - Drug Insight and Market Forecast - 2030” report outlays comprehensive insights of the product indicated for the treatment of its approved condition. A detailed picture of the Nerlynx ...

  • Europe
  • Japan
  • Clinical Trial
  • Breast Cancer
  • Industry analysis
  • Health Expenditure

BETALUTIN - Emerging Insight and Market Forecast - 2030

  • $ 3250
  • February 2021
  • 30 pages

“BETALUTIN - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for Follicular lymphoma in 7 Major Markets. A detailed picture ...

  • Europe
  • Japan
  • Lymphoma
  • Industry analysis
  • Health Expenditure

PEMBROLIZUMAB - Emerging Insight and Market Forecast - 2030

  • $ 3250
  • February 2021
  • 30 pages

“PEMBROLIZUMAB - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for Follicular lymphoma in 7 Major Markets. A detailed picture ...

  • Europe
  • Japan
  • Lymphoma
  • Research And Development
  • Industry analysis
  • Health Expenditure

IXAZOMIB - Emerging Insight and Market Forecast - 2030

  • $ 3250
  • February 2021
  • 30 pages

“IXAZOMIB - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for Follicular lymphoma in 7 Major Markets. A detailed picture of ...

  • Europe
  • Japan
  • Lymphoma
  • Research And Development
  • Industry analysis
  • Health Expenditure

Kalydeco - Drug Insight and Market Forecast - 2030

  • $ 2750
  • February 2021
  • 30 pages

Overview “ Kalydeco - Drug Insight and Market Forecast - 2030” report outlays comprehensive insights of the product indicated for the treatment of its approved condition. A detailed picture of the ...

  • Europe
  • Japan
  • Cystic Fibrosis
  • Clinical Trial
  • Industry analysis
  • Health Expenditure
  • Use Of Prescription Drugs

Lucentis - Drug Insight and Market Forecast - 2030

  • $ 2750
  • February 2021
  • 30 pages

Overview “ Lucentis - Drug Insight and Market Forecast - 2030” report outlays comprehensive insights of the product indicated for the treatment of its approved condition. A detailed picture of the ...

  • Europe
  • World
  • Clinical Trial
  • Type 2 Diabetes
  • Industry analysis
  • Health Expenditure

Rhopressa - Drug Insight and Market Forecast - 2030

  • $ 2750
  • February 2021
  • 30 pages

Overview “Rhopressa - Drug Insight and Market Forecast - 2030” report outlays comprehensive insights of the product indicated for the treatment of its approved condition. A detailed picture of the ...

  • Europe
  • Japan
  • Ophthalmology
  • Clinical Trial
  • Industry analysis
  • Health Expenditure
  • Drug Approval

Obinutuzumab - Drug Insight and Market Forecast - 2030

  • $ 2750
  • February 2021
  • 30 pages

Overview “Obinutuzumab - Drug Insight and Market Forecast - 2030” report outlays comprehensive insights of the product indicated for the treatment of its approved condition. A detailed picture of ...

  • Europe
  • Japan
  • Lymphoma
  • Clinical Trial
  • Industry analysis
  • Health Expenditure

Symdeko - Drug Insight and Market Forecast - 2030

  • $ 2750
  • February 2021
  • 30 pages

Overview “Symdeko - Drug Insight and Market Forecast - 2030” report outlays comprehensive insights of the product indicated for the treatment of its approved condition. A detailed picture of the Symdeko ...

  • Europe
  • Japan
  • Cystic Fibrosis
  • Clinical Trial
  • Industry analysis
  • Health Expenditure

Trikafta - Drug Insight and Market Forecast - 2030

  • $ 2750
  • February 2021
  • 30 pages

Overview “ Trikafta - Drug Insight and Market Forecast - 2030” report outlays comprehensive insights of the product indicated for the treatment of its approved condition. A detailed picture of the ...

  • Europe
  • Japan
  • Clinical Trial
  • Cystic Fibrosis
  • Industry analysis
  • Health Expenditure

ME-401 - Emerging Insight and Market Forecast - 2030

  • $ 3250
  • February 2021
  • 30 pages

“ME-401 - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for Follicular lymphoma in 7 Major Markets. A detailed picture of ...

  • World
  • Europe
  • Lymphoma
  • Industry analysis
  • Health Expenditure

ABEXINOSTAT- Emerging Insight and Market Forecast - 2030

  • $ 3250
  • February 2021
  • 30 pages

“ABEXINOSTAT- Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for Follicular lymphoma in 7 Major Markets. A detailed picture ...

  • Europe
  • Japan
  • Lymphoma
  • Industry analysis
  • Health Expenditure

ODRONEXTAMAB - Emerging Insight and Market Forecast - 2030

  • $ 3250
  • February 2021
  • 30 pages

“ODRONEXTAMAB - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for Follicular lymphoma in 7 Major Markets. A detailed picture ...

  • Europe
  • Japan
  • Lymphoma
  • Industry analysis
  • Health Expenditure

Copiktra - Drug Insight and Market Forecast - 2030

  • $ 2750
  • February 2021
  • 30 pages

Overview “Copiktra - Drug Insight and Market Forecast - 2030” report outlays comprehensive insights of the product indicated for the treatment of its approved condition. A detailed picture of the ...

  • Europe
  • Japan
  • Lymphoma
  • Clinical Trial
  • Industry analysis
  • Health Expenditure

UMBRALISIB - Emerging Insight and Market Forecast - 2030

  • $ 3250
  • February 2021
  • 30 pages

“UMBRALISIB - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for Follicular lymphoma in 7 Major Markets. A detailed picture ...

  • Europe
  • Japan
  • Lymphoma
  • Industry analysis
  • Health Expenditure

PARSACLISIB - Emerging Insight and Market Forecast - 2030

  • $ 3250
  • February 2021
  • 30 pages

“PARSACLISIB - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for Follicular lymphoma in 7 Major Markets. A detailed picture ...

  • Europe
  • Japan
  • Lymphoma
  • Industry analysis
  • Health Expenditure

Tazverik - Drug Insight and Market Forecast - 2030

  • $ 2750
  • February 2021
  • 30 pages

Overview “Tazverik - Drug Insight and Market Forecast - 2030” report outlays comprehensive insights of the product indicated for the treatment of its approved condition. A detailed picture of the ...

  • Europe
  • Japan
  • Lymphoma
  • Clinical Trial
  • Industry analysis
  • Health Expenditure

BI 764524 - Emerging Insight and Market Forecast - 2030

  • $ 3250
  • February 2021
  • 30 pages

“BI 764524 - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for Diabetic Retinopathy in 7 Major Markets. A detailed picture ...

  • Europe
  • Japan
  • Type 2 Diabetes
  • Research And Development
  • Industry analysis
  • Health Expenditure

ACALABRUTINIB - Emerging Insight and Market Forecast - 2030

  • $ 3250
  • February 2021
  • 30 pages

“ACALABRUTINIB - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for Diffuse large B cell lymphoma in 7 Major Markets. A detailed ...

  • Europe
  • Japan
  • Lymphoma
  • Industry analysis
  • Health Expenditure

BLINATUMOMAB - Emerging Insight and Market Forecast - 2030

  • $ 3250
  • February 2021
  • 30 pages

“BLINATUMOMAB - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for Diffuse large B-cell lymphoma (DLBCL) in 7 Major Markets. ...

  • Europe
  • Japan
  • Monoclonal Antibody
  • Lymphoma
  • Industry analysis
  • Health Expenditure

DB-102 - Emerging Insight and Market Forecast - 2030

  • $ 3250
  • February 2021
  • 30 pages

“DB-102 - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for Diffuse large B cell lymphoma in 7 Major Markets. A detailed picture ...

  • Europe
  • World
  • Lymphoma
  • Research And Development
  • Industry analysis
  • Health Expenditure

LONCASTUXIMAB TESIRINE - Emerging Insight and Market Forecast - 2030

  • $ 3250
  • February 2021
  • 30 pages

“LONCASTUXIMAB TESIRINE - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for Diffuse large B cell lymphoma in 7 Major Markets. ...

  • Europe
  • Japan
  • Lymphoma
  • Therapy
  • Industry analysis
  • Health Expenditure

TREAKISYM - Emerging Insight and Market Forecast - 2030

  • $ 3250
  • February 2021
  • 30 pages

“TREAKISYM - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for Diffuse large B cell lymphoma in 7 Major Markets. A detailed ...

  • Europe
  • Japan
  • Lymphoma
  • Industry analysis
  • Health Expenditure

UBLITUXIMAB + UMBRALISIB - Emerging Insight and Market Forecast - 2030

  • $ 3250
  • February 2021
  • 30 pages

“UBLITUXIMAB + UMBRALISIB - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for Diffuse Large B-Cell Lymphoma in 7 Major Markets. ...

  • Europe
  • Japan
  • Lymphoma
  • Therapy
  • Industry analysis
  • Health Expenditure

Reportlinker.com © Copyright 2022. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on